Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIST: HSCT vs Standard of Care in Inflammatory MS
NCT00273364Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Nov 2005
- Primary completion
- Jan 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous hematopoietic stem cells in multiple sclerosis (MS), sponsored by Northwestern University. Started Nov 2005; status: completed.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00273364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273364.